Universidad Popular Autónoma del Estado de Puebla Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2009
NCT02439879
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Centro de Hematología y Medicina Interna | Laboratorios Clínicos de Puebla (Laboratorios Ruiz) | Universidad Popular Autonoma del Estado de Puebla

Active Ingredients

Drugs in Phase 4 Trials (1)

alpha-lipoic acid (1 trial)

Drugs in Phase 2 Trials (1)

COVID-19 convalescent plasma (1 trial)

Drugs in Other Trials (1)

cyclophosphamide (cytoxan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 2)

Diabetic Neuropathies (Phase 4)

Severe Acute Respiratory Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3